Abeona Therapeutics Inc. ABEO

Set alert

Price alert · ABEO

All alert types
4.25 USD -0.10 -2.30%

At close

4.11 -0.14 -3.29%

Pre-market · Nov 3, 6:06 AM ET

Bid
4.26 × 1
Ask
4.27 × 1
4.16 Day range 4.46
4.00 52-week range 7.65
YTD
-19.35%
1 year
-11.64%
Open
4.43
Prev close
4.35
Mkt cap
243.03M
Vol
1.01M
Avg vol
1.35M
EPS
-1.18
P/E
0.00
Div yield
0.00%
More statistics
Low
4.16
High
4.46
Forward P/E
-3.84
Beta
1.50
Short ratio
10.79
Inst. own
77.54%
Dividend
0.00
Ex-div date
50-d avg
6.15
200-d avg
5.64
1y target
16.75

1D chart

Chart tools
Interval

Signals (32)
NameTimeAgo
MACD: Buy Signal3:43 PM15 hours ago
MACD: Sell Signal3:28 PM15 hours ago
MACD: Buy Signal3:23 PM15 hours ago
MACD: Sell Signal3:07 PM15 hours ago
RSI: Overbought3:03 PM15 hours ago
RSI: Overbought2:52 PM16 hours ago
MACD: Buy Signal2:43 PM16 hours ago
MACD: Sell Signal2:21 PM16 hours ago
MACD: Buy Signal1:59 PM16 hours ago
RSI: Oversold1:41 PM17 hours ago
MACD: Sell Signal1:35 PM17 hours ago
SMA: Bullish1:27 PM17 hours ago
MACD: Buy Signal1:27 PM17 hours ago
SMA: Bearish1:06 PM17 hours ago
MACD: Sell Signal12:52 PM18 hours ago
SMA: Bullish12:35 PM18 hours ago
SMA: Bullish12:35 PM18 hours ago
MACD: Buy Signal12:32 PM18 hours ago
RSI: Oversold12:25 PM18 hours ago
SMA: Bearish12:02 PM18 hours ago

Newest 20 of 32.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 16.75 +294.1% upside
Target (low)
9.50
Target (mean)
16.75
Target (high)
21.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ABEO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.34-0.34 – -0.34-0.4802+29.2%83.33K0.0%2
Next quarter-0.385-0.39 – -0.38-0.5227+26.3%125.00K0.0%2
Current year-1.56-1.57 – -1.55-1.94+19.5%83.33K-97.6%2
Next year-1.13-1.20 – -1.05-1.56+27.9%18.81M+22478.5%2

Upgrades and downgrades

The latest rating changes

ABEO analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 29, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 3, 2024HC Wainwright & Co.Initiated—Buy
May 30, 2024StifelInitiated—Buy
May 16, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Apr 23, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 24, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Jul 13, 2023Cantor FitzgeraldReiteratedOverweightOverweight
May 24, 2023Alliance Global PartnersReiterated—Buy
Nov 14, 2022SVB LeerinkMaintained—Market Perform
Nov 8, 2022Cantor FitzgeraldMaintained—Overweight
Aug 11, 2022SVB LeerinkMaintained—Market Perform